Format

Send to

Choose Destination
See comment in PubMed Commons below
Genes Dev. 1998 Feb 15;12(4):456-61.

Expression of NPAT, a novel substrate of cyclin E-CDK2, promotes S-phase entry.

Author information

  • 1Laboratory of Molecular Oncology, Massachusetts General Hospital (MGH) Cancer Center, Charlestown, Massachusetts 02129, USA. zhao@helix.mgh.harvard.edu

Abstract

To understand the mechanisms by which CDKs regulate cell cycle progression, it is necessary to identify and characterize the physiological substrates of these kinases. We have developed a screening method to identify novel CDK substrates. One of the cDNAs identified in the screen is identical to the recently isolated NPAT gene. Here we show that NPAT associates with cyclin E-CDK2 in vivo and can be phosphorylated by this CDK. The protein level of NPAT peaks at the G1/S boundary. Overexpression of NPAT accelerates S-phase entry, and this effect is enhanced by coexpression of cyclin E-CDK2. These results suggest that NPAT is a substrate of cyclin E-CDK2 and plays a role in S-phase entry.

PMID:
9472014
PMCID:
PMC316526
[PubMed - indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire Icon for PubMed Central
    Loading ...
    Write to the Help Desk